Aarkstore - PharmaSphere: Emerging Biotechnologies

1. Category : Pharmaceuticals and Healthcare Aarkstore - PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy

2. Summary "PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy", provides strategic analysis of the global stem cells industry. It discusses key development trends, regulatory requirements in various markets, recent deals activity and industry dynamic trends, as well as describes the operations strategy of these companies. Furthermore, it includes a geographical segmentation of various markets including the EU and US, as well as emerging markets such as China, India, SouthKorea, and Israel-providing in-depth analysis of these markets regulatory framework, key domestic players and their stem cell pipelines, and strategic outlook. Throughout the report, GlobalDatas analysts provide you with expert insight, expanding on each strategy and factor discussed, with the aim of providing you with the tools needed for making informed business decisions. Browse Complete Report – http://www.aarkstore.com/pharmaceuticals-healthcare/62815/pharmasphere-emerging-biotechnologies-stem-cell-therapy

3. Highlights Key Questions Answered - (Q.) What are the key market drivers of the global stem cell industry? - (Q.) Who are the top players involved in the development of stem cell therapies in developed as well as developing countries? - (Q.) What are the main regulatory measures affecting the stem cell industry in the US, Europe, Japan, India, South Korea, China and Israel? - (Q.) What are the major trends in stem cell clinical trials and profiles of key investigators? - (Q.) What specific strategies are companies utilizing to combat some of the challenges currently facing the development of therapies in the global stem cell industry?

4. Scope - Stem Cell Market Dynamics: This report provides analysis of the key drivers and trends shaping the global Stem Cell therapy market, including manufacturing, emerging markets, and development pipeline. - Financial Performance Insight: Report uses GlobalDatas proprietary data across 22 key financial metrics to provide insight over stem cell company performance. - PipelineAnalysis: Detailed information on ten leading stem cell therapies; trend analysis of clinical trial studies and investigators covering over 1000 trials related to stem cell therapies. - Deal strategies: Exhaustive discussion on the strategic implications and synergies of deals including, M&A, collaboration as well as capital raisings such as equity offerings, private equity and venture financing activities.

5. Table of Content 1.1 List of Tables 14 1.2 List of Figures 19 2 Introduction 22 2.1 Report Scope 22 2.2 Upcoming Related Reports 24 2.3 Recently Published Reports 24 3 Stem Cell Overview 25 3.1 Definition 25 3.1.1 Renewal 25 3.1.2 Potency 25 3.2 Types of Stem Cell 26 3.2.1 Embryonic Stem Cells 27

6. List of Tables Table 1: Milestones in Stem Cell Research 29 Table 2: Platform Technologies Adopted from Academic Institutions 43 Table 3: Prochymal 44 Table 4: Adult Autologous CD34+ Stem Cells 45 Table 5: StemEx 46 Table 6: Allogeneic MPC For Bone Marrow Transplantation 47 Table 7: Preob 48 Table 8: Cerecellgram 49 Table 9: Revascor 50 Table 10: Tumor Stem Cell Specific Dendritic Cell Therapy 51 Table 11: GSK-2696273 52

7. List of Tables Table 1: Milestones in Stem Cell Research 29 Table 2: Platform Technologies Adopted from Academic Institutions 43 Table 3: Prochymal 44 Table 4: Adult Autologous CD34+ Stem Cells 45 Table 5: StemEx 46 Table 6: Allogeneic MPC For Bone Marrow Transplantation 47 Table 7: Preob 48 Table 8: Cerecellgram 49 Table 9: Revascor 50 Table 10: Tumor Stem Cell Specific Dendritic Cell Therapy 51 Table 11: GSK-2696273 52 Table 12: Lenti-D (Bluebird bio) 53 Table 13: Highlighted M&A Deals, January 1, 2004-March 1, 2014 82

8. List of Figures Figure 1: Number of Unique Stem Cell Therapies Per Company 36 Figure 2: Number of Stem Cell Therapy Indications Per Company (Top 27) 37 Figure 3: Stem Cell Therapy Programs by Stage of Development 38 Figure 4: Stem Cell Pipeline by Therapy Area 39 Figure 5: Stem Cell Pipeline By Indication (Top 31) 40 Figure 6: Stem Cell Pipeline by Number of Indications Under Investigation 41 Figure 7: Stem Cell Clinical Trials Annual Trend, 2004-2014 55 Figure 8: Stem Cell Clinical Trials by Phase of Development, 2004-March 1, 2014 56 Figure 9: Stem Cell Clinical Trials by Status, January 1, 2004-March 1, 2014 57 Figure 10: Stem Cell Clinical Trials by Therapy Area, January 1, 2004-March 1, 2014 58 Figure 11: Stem Cell Clinical Trials Top 20 Indications, January 1, 2004-March 1, 2014 59 Figure 12: Stem Cell Clinical Trials Top 15 Countries, January 1, 2004-March 1, 2014 60

9. Related reports: • Essential Thrombocythemia - Pipeline Review, H1 2015 • Oligodendroglioma - Pipeline Review, H1 2015 • Inclusion Body Myositis (IBM) - Pipeline Review, H1 2015 • Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2015 • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2015 • Fabry Disease-Pipeline Insights, 2015 • Ocular Hypertension-Pipeline Insights, 2015 • Shock-Pipeline Insights, 2015 • Fallopian Tube Cancer-Pipeline Insights, 2015

10. PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy Published: Nov 2014 | 248 Pages "PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy", provides strategic analysis of the global stem cells industry Price

11. Contact Us Office Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Telefax No: +91 22 4127 6660 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit http://www.aarkstore.com OR Mail us at contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news